423 filings
Page 4 of 22
8-K
0h5yy95a4ig
10 Aug 22
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:06pm
8-K/A
tsu8c 8q2
25 Jul 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
bg8wt15
20 Jul 22
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
8:01am
424B5
k9iqb6y39l
10 Jun 22
Prospectus supplement for primary offering
5:19pm
8-K
sj4myi
3 Jun 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
2dl5uilbc74o
10 May 22
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:01pm
DEFA14A
ctm90xmd
21 Apr 22
Additional proxy soliciting materials
4:30pm
S-8
rbzu6av
31 Mar 22
Registration of securities for employees
5:17pm
8-K
x8g3a1srp
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
xsej5y93v6qni7 pe
30 Mar 22
Prospectus supplement for primary offering
5:21pm
8-K
q7v66do
28 Mar 22
Soleno Therapeutics Announces Proposed Underwritten Public Offering
4:59pm
424B5
mh3 tg2lw
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
1pwhuxo
18 Mar 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
hsl5posh641me
31 Jan 22
Departure of Directors or Certain Officers
4:00pm
8-K
waucw6e
24 Jan 22
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome
8:06am
8-K
qm9fku00o1ihi
30 Dec 21
Entry into a Material Definitive Agreement
4:37pm